SCHEMBL4943065

SCHEMBL4943065

COc1ccc(C2=NN(c3ccc(CC(=O)N4CCOCC4)cc3)C(=O)C(C)(C)C2)cc1OC

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTT P42858 1/20 0.57
GFER P55789 1/20 0.46
KMT2A Q03164 2/20 0.45
MAPK1 P28482 2/20 0.45
MEN1 O00255 1/20 0.45
CYP2C19 P33261 1/20 0.45
PDE4D Q08499 1/20 0.45
TP53 P04637 1/20 0.45
PKM P14618 1/20 0.45
NPSR1 Q6W5P4 1/20 0.45
JAK2 O60674 2/20 0.44
JAK1 P23458 2/20 0.44
TYK2 P29597 1/20 0.44
JAK3 P52333 1/20 0.44
MAPT P10636 4/20 0.44
PDE4B Q07343 3/20 0.43
NPC1 O15118 1/20 0.43
KDM4E B2RXH2 1/20 0.41
ALDH1A1 P00352 1/20 0.41
HPGD P15428 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4943419 0.88 TP53 (0.55) MAPK1TP53MAPTNPC1KDM4E
SCHEMBL4937607 0.88 MAPT (0.54) HTTKMT2AMAPK1MEN1PDE4D
SCHEMBL4937419 0.85 PDE4B (0.53) PDE4DPDE4BKDM4EALDH1A1HPGD
SCHEMBL4942500 0.85 MAPT (0.48) KMT2AMEN1CYP2C19PDE4DPKM
SCHEMBL4944659 0.82 MAPT (0.48) KMT2AMAPK1MEN1PDE4DPKM
Hydrochloric Acid SCHEMBL4945220 0.82 TLR9 (0.51) HTTKMT2AMEN1PDE4DPKM
SCHEMBL4944690 0.79 PDE5A (0.53) KMT2AMEN1PDE4DPDE4BALDH1A1
SCHEMBL4945670 0.79 PDE4B (0.51) PDE4DPDE4B
Hydrochloric Acid SCHEMBL4942882 0.78 TP53 (0.49) KMT2AMAPK1MEN1TP53MAPT
SCHEMBL4940552 0.77 PDE4B (0.51) PDE4DPDE4B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080227790-A1 Pyridazinone Derivatives and their Use as Pde4 Inhibitors ALTANA PHARMA AG (DE) 2008-09-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080227790-A1 Pyridazinone Derivatives and their Use as Pde4 Inhibitors PDE4A, PDE4B, PDE5A HTT 4667/4885GFER 4118/4885KMT2A 3218/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.